Aurora-A Kinase Is Essential for Bipolar Spindle Formation and Early Development by Cowley, D. O. et al.
MOLECULAR AND CELLULAR BIOLOGY, Feb. 2009, p. 1059–1071 Vol. 29, No. 4
0270-7306/09/$08.000 doi:10.1128/MCB.01062-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
Aurora-A Kinase Is Essential for Bipolar Spindle Formation and
Early Development†
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Aurora-A is a conserved kinase implicated in mitotic regulation and carcinogenesis. Aurora-A was
previously implicated in mitotic entry and spindle assembly, although contradictory results prevented a
clear understanding of the roles of Aurora-A in mammals. We developed a conditional null mutation in
the mouse Aurora-A gene to investigate Aurora-A functions in primary cells ex vivo and in vivo. We show
here that conditional Aurora-A ablation in cultured embryonic fibroblasts causes impaired mitotic entry
and mitotic arrest with a profound defect in bipolar spindle formation. Germ line Aurora-A deficiency
causes embryonic death at the blastocyst stage with pronounced cell proliferation failure, mitotic arrest,
and monopolar spindle formation. Aurora-A deletion in mid-gestation embryos causes an increase in
mitotic and apoptotic cells. These results indicate that murine Aurora-A facilitates, but is not absolutely
required for, mitotic entry in murine embryonic fibroblasts and is essential for centrosome separation and
bipolar spindle formation in vitro and in vivo. Aurora-A deletion increases apoptosis, suggesting that
molecular therapies targeting Aurora-A may be effective in inducing tumor cell apoptosis. Aurora-A
conditional mutant mice provide a valuable system for further defining Aurora-A functions and for
predicting effects of Aurora-A therapeutic intervention.
The equal partitioning of chromosomes at mitosis is critical
for avoiding aneuploidy, a condition associated with spontane-
ous miscarriage, developmental disorders, and cancer (50).
Mitosis requires coordinated completion of multiple events
including nuclear envelope breakdown, chromosome conden-
sation and congression to the metaphase plate, centrosome
separation, spindle formation, chromosome-spindle attach-
ment and error correction, sister chromatid separation, and
cytokinesis. Multiple regulators, many of which are kinases, are
required to ensure that each event is completed in a timely
fashion and in the proper order (reviewed in reference 46).
Although a number of mitotic kinases have been identified,
their targets and the intricacies of mitotic signal transduction
pathways are just beginning to be understood.
The Aurora kinases are key mitotic regulators in eukaryotes
(reviewed in reference 45). The Aurora family includes a single
member in yeasts (Saccharomyces cerevisiae Ipl1p, Schizosac-
charomyces pombe Ark1), two members each in Caenorhabditis
elegans and Drosophila, and two or three members in verte-
brates. Although originally given a variety of names, Aurora
kinases in multicellular eukaryotes have subsequently been
classified into A, B, and C groups based on patterns of mitotic
subcellular localization and homology, which also appear to
reflect functional distinctions (8, 46). Aurora-A kinases are
observed at centrosomes and adjacent spindle fibers, and cur-
rent evidence supports key roles in regulating protein localiza-
tion and function at centrosomes, as well as regulation of the
assembly, stability, and function of the mitotic spindle (re-
viewed in reference 43). Aurora-B kinases display “chromo-
somal passenger” localization, residing on mitotic chromo-
somes and subsequently moving to the spindle midzone after
separation of sister chromatids. Aurora-B family members
have been implicated in the regulation of kinetochore-spindle
attachment, the spindle checkpoint, and cytokinesis (reviewed
in references 1 and 8). Aurora-C kinases, which have only been
identified in mammals, have a limited expression pattern and
appear to have functions that overlap those of Aurora-B (7,
53).
The human Aurora-A kinase (hAurA) was first identified
because of its overexpression in cancer cell lines (5, 58). The
hAurA gene (stk15) resides on chromosome 20q13, a region
frequently amplified in human cancers (5, 58). hAurA has been
dubbed an oncogene because of the fact that its overexpression
transforms immortalized rodent fibroblasts (5, 70). Polymor-
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phisms in hAurA are associated with an increased risk of colon
cancer, while murine AurA (mAurA) polymorphisms confer
increased susceptibility to experimentally induced skin tumors
(14). The mAurA gene is frequently amplified in radiation-
induced lymphomas from p53 heterozygous mice, while loss of
one mAurA allele has been observed in lymphomas from p53-
null mice (41). Thus, aberrant AurA expression is associated
with tumorigenesis, suggesting that insight into AurA functions
will lead to a better understanding of tumorigenesis mecha-
nisms.
A number of experimental observations suggest that AurA
kinases are required for normal centrosome maturation and
bipolar spindle assembly. The AurA ortholog in Drosophila
melanogaster (Aurora) was identified in a screen for mutations
that impact the centrosome cycle (21). Syncytial embryos from
hypomorphic Aurora mutant females display a variety of mi-
totic abnormalities resulting from a failure to separate centro-
somes. Aurora-null flies die at the larval stage with character-
istic monopolar spindles and circular chromosome arrays in
larval neuroblasts. Such monopolar spindles arise from failed
centrosome separation (21). Subsequent studies of Drosophila
Aurora mutant alleles revealed additional defects in centro-
some maturation (including a failure to localize transforming
acidic coiled-coil protein, centrosomin, and -tubulin at cen-
trosomes) and in asymmetric localization of Numb protein in
sensory organ precursor cells (3, 17). Similar to the case in
Drosophila, disruption of the C. elegans AurA ortholog AIR-1
by RNA interference (RNAi) or mutation causes defects in
centrosome maturation and monopolar spindle formation.
Centrosomes undergo normal separation but collapse, leading
to monopolar spindle formation (16, 24, 56). Studies of the
Xenopus AurA homolog pEg2 revealed similar phenotypes af-
ter overexpression of kinase-dead mutants, antibody-mediated
inhibition, or immunodepletion (18, 19, 38, 52). Furthermore,
Xenopus AurA has been shown to interact with and phosphor-
ylate Eg5, a mitotic kinesin required for bipolar spindle for-
mation, suggesting a possible mechanism by which AurA could
influence bipolar spindle formation and/or stabilization (19).
Thus, existing reports from these systems are quite consistent
in implicating AurA in centrosome separation and function.
In contrast to the systems described above, published reports
of RNAi-mediated reduction of AurA expression in mamma-
lian cell lines have contained conflicting results about the role
of AurA in mitotic entry, bipolar spindle formation, and mi-
totic progression. AurA RNAi in HeLa cells was reported to
block or delay mitotic entry, prompting the conclusion that
AurA is essential for mitotic commitment in mammalian cells
(27, 36). In contrast, other AurA RNAi studies showed accu-
mulation of mitotic cells with monopolar spindles (12, 20, 67).
These discrepancies call into question the functional conser-
vation of AurA in mammals and highlight a need for additional
studies to definitively address the roles of AurA. This is par-
ticularly critical for understanding the roles of AurA in cancer
and for projecting possible effects of AurA inhibitors currently
in development as anticancer agents. We used gene targeting
in mouse embryonic stem (ES) cells to produce a conditional
null allele at the AurA locus. Here we describe cellular phe-
notypes of AurA deletion in primary cells in vitro and devel-
opmental phenotypes of AurA mutant mice. We show that
AurA deletion in primary embryonic fibroblasts causes delayed
mitotic entry with accumulation of cells in early prophase,
consistent with a role for AurA in mitotic entry. Nevertheless,
AurA-deficient cells that enter prometaphase arrest with
monopolar spindles and eventually exit mitosis without seg-
regating their chromosomes. Prolonged culture of AurA-
deficient cells leads to polyploidy with abnormal nuclear struc-
ture. Germ line AurA deficiency causes embryonic death at the
blastocyst stage with mitotic arrest and monopolar spindle
formation, while AurA deletion in mid-gestation embryos
causes an increased mitotic index and increased apoptosis.
Together, our findings indicate that AurA is required for
timely mitotic entry and bipolar spindle formation in vitro and
in vivo.
MATERIALS AND METHODS
AurA gene targeting and mice. AurA genomic bacterial artificial chromosome
clones were isolated from a 129SvEv library by hybridization screening and
subsequent PCR verification. Bacterial strain EL350 (37) was used for “recom-
bineering” to subclone a 13-kb fragment encompassing AurA exons 1 to 6 into a
pUC19-based plasmid including a negative-selection thymidine kinase gene (a
gift of R. Thresher, University of North Carolina animal models core facility). A
loxP site was inserted into intron 2 by recombineering a loxP-flanked zeocin
cassette, followed by Cre-mediated cassette removal in EL350. A loxP- and
FRT-flanked neomycin resistance cassette was subsequently inserted into a
unique SalI restriction site in intron 1. The targeting vector was linearized and
used for gene targeting in line E14 ES cells (129P2/OlaHsd strain). ES cell
targeting was verified by PCR and Southern blotting, and correctly targeted
clones were injected into C57BL/6J blastocysts for chimera generation. Chimeric
males were bred with C57BL/6J females, and germ line transmission of the
AurAneo allele was verified by PCR. The AurAd2 and AurAf alleles were generated
by crossing the AurAneo allele with an X-linked CMV-Cre strain (61). Recom-
bined alleles were backcrossed for at least 2 generations to C57BL/6J mice
before use in this study. R26CreER (2) and R26Rep (60) mice were obtained from
Jackson Laboratories. For the PCR primers used and genotyping information for
the AurA mutant alleles, see Table S1 in the supplemental material.
MEFs. Murine embryonic fibroblasts (MEFs) were generated from embryonic
day 14.5 (E14.5) embryos by standard protocols. MEFs were grown in Dulbecco
modified Eagle medium (DMEM) with 4,500 mg/liter D-glucose and supple-
mented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 50 U/ml peni-
cillin, 50 g/ml streptomycin, and 55 M 2-mercaptoethanol in a humidified
incubator with 5% CO2 and passaged every 2 to 3 days. All experiments were
performed with cells at passages 3 to 5. -Galactosidase detection was performed
by a standard 5-bromo-4-chloro-3-indolyl--D-galactopyranoside (X-Gal) stain-
ing protocol (59). For immunofluorescence (IF) experiments, cells were grown
on acid-washed glass coverslips coated with poly-L-lysine. Coverslips were fixed
in 2% formaldehyde in phosphate-buffered saline (PBS) for 20 to 30 min and
stored in PBS with 0.1% sodium azide at 4°C until used. Primary antibodies were
anti-Aurora-A (IAK1; BD Biosciences no. 610938, 1:500 dilution), anti--tubulin
(rat monoclonal, 1:200 dilution), anti--tubulin (Sigma T5192, 1:1,000 dilution),
anti--tubulin (Sigma T4026, 1:200 dilution), anti-XMad2 (affinity-purified rab-
bit polyclonal, 1:1,000 dilution) (66), and anti-phosphorylated histone H3 (anti-
PH3; serine 10; Upstate Biotech, 06-570, 1:500 dilution). 4-Hydroxytamoxifen
(OHT; Sigma H7904) was dissolved in 100% ethanol and used at 50 nM for all
experiments.
Flow cytometry. Adherent cells were removed from plates by trypsinization
and pooled with cell culture supernatant containing nonadherent cells. Cells
were washed once with PBS, fixed in cold 70% ethanol, and stored at 20°C until
analyzed. For staining, 1  106 cells were washed in PBS and stained in PBS with
50 g/ml propidium iodide, 200 g/ml boiled RNase A, and 0.1% Triton X-100.
Analyses were performed on a BD FACScan flow cytometer and analyzed with
Summit software (Dako).
Time-lapse imaging. AurA/; R26CreER/ and AurAf/f; R26CreER/ cells were
incubated in DMEM–0.1% FBS for 24 h, after which 50 nM OHT was added for
an additional 24 h of incubation. Cell cycle entry was stimulated by replacing the
medium with fresh DMEM with 10% FBS for 14 h of incubation, followed by the
addition of fresh DMEM–10% FBS–10 mM HEPES, pH 7.4, for an additional
3 h of incubation prior to live-cell imaging. Time-lapse images were captured on
an Olympus IX70 microscope with a custom-built environmental chamber. Im-
ages were taken every 10 min for 50 h. Images were analyzed with OpenLab
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software (Improvision) and QuickTime (Apple). Mitotic entry was judged as the
point of cell rounding, and mitotic exit was judged as the point at which cells
flattened out. Each experiment was repeated with MEFs from two different
embryos. Differences in mitotic timing were compared by Kaplan-Meier analysis.
For representative movies and phenotype images, see the supplemental material.
Immunoblotting. Cells were harvested at the indicated time points, washed in
PBS, counted, and lysed by boiling in sodium dodecyl sulfate (SDS) sample
buffer (60 mM Tris-HCl [pH 6.8], 10% glycerol, 2% SDS, 100 mM dithiothrei-
tol). Volumes representing equal cell numbers were separated by 4 to 20%
SDS-polyacrylamide gel electrophoresis and transferred to polyvinylidene diflu-
oride membranes. Membranes were blocked in 5% nonfat dry milk in PBS with
0.1% Tween 20 (block) and incubated with antibodies diluted in block at room
temperature (RT) for 1 to 2 h or overnight at 4°C. Membranes were washed
extensively in PBS with 0.1% Tween 20 and incubated with horseradish perox-
idase-conjugated secondary antibodies for 1 h at RT in block. Following exten-
sive washes, targets were detected with a SuperSignal West Pico Chemilumines-
cent Substrate kit (Pierce).
Blastocyst culture and staining. Timed matings were set, and the morning of
vaginal plug detection was considered E0.5. Blastocysts were flushed from the
uteri of pregnant females at E3.5. Blastocysts were cultured in drops of DMEM
with 4,500 mg/liter D-glucose, 15% FBS, 2 mM L-glutamine, 50 U/ml penicillin,
50 g/ml streptomycin, and 55 M 2-mercaptoethanol overlaid with mineral oil
in a humidified incubator with 5% CO2. Outgrowths were photographed after 5
to 7 days and harvested for genotyping. DNA lysates were prepared by the
HotShot method (63). For immunostaining, freshly isolated blastocysts were
rinsed in PBS and fixed in fresh 4% formaldehyde in PBS for 30 to 60 min at RT.
Blastocysts were subsequently rinsed in PBS; washed three times for 10 min each
in PBS with 1% bovine serum albumin and 0.5% Triton X-100 (PBT); blocked
for 1 h in PBT with 5% goat serum (Block); incubated overnight with primary
antibodies diluted in block; washed three times for 10 min each in PBT; incu-
bated for 1 h with secondary antibodies in PBT; washed three times for 10 min
each in PBT, one time in PBS, once in a 1:2 mixture of glycerol-PBS, and once
in 1:1 glycerol-PBS; and mounted in mounting medium with 4,6-diamidino-2-
phenylindole (DAPI). All incubations were performed at 25°C. The primary
antibodies used were mouse monoclonal anti-Aurora-A (IAK1; BD Biosciences
no. 610938, 1:500 dilution) and rat monoclonal anti--tubulin (1:200 dilution).
Images were analyzed on a Leica SP2 laser scanning confocal microscope with a
40 objective (1.25 numerical aperture).
RESULTS
Conditional inactivation of murine Aurora-A. To better un-
derstand the functions of AurA in development and cancer, we
generated a conditional AurA allele by gene targeting in mouse
ES cells (Fig. 1). The AurA locus includes nine exons, with
potential translational start codons in exons 1 and 2. The tar-
geting strategy was designed to flank AurA exon 2 with loxP
sites, allowing Cre-mediated exon 2 deletion. Exon 2 deletion
was predicted to produce a null allele because of removal of
the main ATG codon and by causing a frameshift of any pro-
tein produced from the upstream ATG codon after the 20th
amino acid (the resulting protein would also include 13 out-
of-frame amino acids prior to a stop codon). The targeting
construct produced the AurAneo allele, which incorporates a
loxP- and FRT-flanked neomycin resistance (neo) cassette in
intron 1 and a single loxP site in intron 2. Correctly targeted ES
cell clones were used to derive chimeric mice that transmitted
the AurAneo allele through the germ line. AurAneo/ mice were
crossed to a Cre deleter strain [HprtTg(CMV-Cre)Brd] (61) to
produce the AurAf (“floxed”) and AurAd2 alleles by deletion of
the neo cassette alone or the neo cassette plus exon 2, respec-
tively. Mice heterozygous for each of the mutant alleles, or
homozygous for the AurAf allele, were viable and fertile and
did not show any overt abnormalities.
Conditional AurA deletion in MEFs. Published reports of
RNAi of AurA expression in mammalian cell lines gave con-
flicting results about the role of AurA in mitotic entry and
progression (12, 20, 27, 36, 67). RNAi usually does not produce
complete inhibition of protein expression and may have off-
target effects that confound interpretation (30, 35, 40). More-
over, HeLa and other established cell lines harbor multiple
genetic abnormalities because of their tumor origins and se-
lection for efficient growth in culture. Therefore, we tested the
effects of genetic AurA deletion in early-passage MEFs to
determine the phenotypes of AurA-null primary cells. MEFs
were derived from intercrosses of AurAf mice harboring a
Rosa26-Cre-ERTM transgene (R26CreER) (2). The R26CreER
transgene drives ubiquitous expression of a Cre-estrogen re-
ceptor fusion protein from the endogenous Rosa26 locus. The
Cre-ERTM molecule is inactive until cells are treated with
tamoxifen or the analog OHT, allowing temporal control over
recombinase activity. The MEF system also included a Cre-
inducible Rosa26–-galactosidase reporter allele (R26Rep), al-
lowing -galactosidase marking of cells that experienced Cre
activity (60). To avoid potential confounding effects of Cre-
mediated DNA damage during the cell cycle (39), we devised
a system to delete AurA in quiescent cells and subsequently
allow cell cycle progression (Fig. 2A). AurA gene expression
and protein stability are regulated by the cell cycle: AurA gene
expression is limited to S/G2/M cells, and AurA protein is
degraded by the proteosome upon G1 entry (5, 11, 15, 22, 29,
FIG. 1. Production of AurA conditional and mutant alleles. (A) Schematic representation of the AurA locus, targeting vector, and mutant
alleles. Exons 1 to 8; Southern blot probes; and HindIII (H), EcoRI (R), and SalI (S) restriction sites are shown. Arrows indicate potential
translational start codons. The targeting vector included a thymidine kinase gene (tk) and a neomycin resistance gene (Neor) flanked by FRT (ovals)
and loxP (triangles) sites. Mice carrying the AurAneo allele were crossed to a Cre recombinase strain to generate the AurAf (conditional) and AurAd2
(null) alleles. (B) Southern blotting of ES cells indicating correct targeting event in the second and fourth clones from the left.
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52, 62, 64). We reasoned that if the Cre recombination oc-
curred in G0- or G1-phase cells, the cells should lack AurA
protein as they traverse subsequent cell cycle phases, providing
a clean system in which to detect mitotic phenotypes. Cells
were arrested by 24 h of serum starvation, followed by 2 days
of additional starvation in the presence of OHT to induce
Cre-ERTM activity in the quiescent cells. Cells were then fed
serum-containing medium without OHT to induce cell cycle
entry in the absence of Cre activity. This protocol gave efficient
recombination of the R26 reporter allele (	85%) and produc-
tion of the Aurd2 allele as assessed by induction of -galacto-
sidase and PCR, respectively (not shown). A background of
approximately 5% recombination was observed in untreated
cultures (data not shown). Immunoblot analyses of control
cells (AurAf/f; R26CreER/Rep without OHT and AurA/;
R26CreER/Rep with OHT) showed the expected pattern of AurA
expression (Fig. 2B). Very little AurA is detected in arrested
cells; the protein is abundant at 24 h, the time when the mitotic
index peaks in the population, and intermediate levels are
detected at 48 h, when the population has reverted to more
asynchronous growth and fewer cells are in mitosis (Fig. 2B).
In contrast, AurA protein was undetectable in OHT-treated
AurAf/f; R26CreER/Rep MEFs at all of the time points tested (Fig.
2B). Semiquantitative reverse transcription-PCR analysis dem-
onstrated very similar AurA mRNA levels in OHT-treated
AurAf/f; R26CreER/Rep and AurA/; R26CreER/Rep MEFs, al-
though primers spanning exon 2 clearly demonstrated that the
deletion had occurred in AurAf/f; R26CreER/Rep cells (Fig. S1).
Thus, the deletion of exon 2 causes a loss of protein expression,
as expected, despite the continued presence of the AurA
mRNA with exon 2 deleted. Together, these results indicate
that the R26CreER transgene provides efficient conversion of
the AurAf allele to the AurAd2 allele and that the AurAd2 allele
is null for protein production. The conditional AurA MEFs
thus provide an excellent system in which to determine the
effects of AurA deletion on cell cycle progression.
To determine phenotypes of AurA loss, we first tested the
growth and ploidy of AurA mutant MEFs over a 5-day time
course after Cre-mediated deletion. OHT-treated AurAf/f;
R26CreER/Rep MEFs displayed a clear growth defect relative to
controls after serum addition (Fig. 2C). Controls included
FIG. 2. AurA mutation causes MEF growth defects and ploidy
changes. (A) Experimental protocol for AurA deletion in quiescent
MEFs. Early-passage MEFs were serum starved for 24 h and then
serum starved for 48 h with OHT. The time of serum addition (without
OHT) is defined as time zero. (B) Immunoblot analysis of AurA
protein expression in OHT-treated MEFs shows that AurA protein is
undetectable following Cre recombination. Cells were treated as
shown in panel A, and samples were harvested at 0, 26, and 49 h after
serum addition. -Tubulin (-Tub) detection confirmed equal loading.
(C) MEF growth curve following the treatment protocol from panel A.
Controls were AurAf/f; R26CreER/Rep cells with OHT treatment (n 
 2),
AurA/; R26CreER/Rep cells with or without OHT (n 
 2 each), and
AurAf/f; R26Rep/Rep cells with or without OHT (n 
 1 each). (D) AurA
deletion causes increased G2/M and endoreduplicating fractions. Cul-
tures were treated with OHT as in panel A and analyzed by fluores-
cence-activated cell sorting for DNA content with propidium iodide.
/ 
 AurA/; R26CreER/Rep; f/f 
 AurAf/f; R26CreER/Rep. (E) AurA
deletion causes an increased PH3 index. Cultures were treated with
OHT as in panel A and analyzed by fluorescence-activated cell sorting
for PH3 staining. / 
 AurA/; R26CreER/Rep; f/f 
 AurAf/f;
R26CreER/Rep. (F) Nuclear atypia following AurA deletion. DAPI-
stained images from cultures 96 h after serum readdition are shown.
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AurAf/f; R26CreER/Rep cells without OHT treatment and
AurA/; R26CreER/Rep cells with and without OHT treatment.
No growth defects were observed in response to OHT treat-
ment in controls, indicating that Cre activity in quiescent cells
does not impact the subsequent cell cycle. We also examined
the cell cycle and ploidy by flow cytometry (Fig. 2D). Control
cells had a normal cell cycle and ploidy profile at all of the time
points examined. In contrast, AurA-deficient cultures dis-
played a dramatic increase in cells with 4N DNA content 28 h
after serum addition, and this population remained elevated
throughout the 96-h observation period. AurA mutant cultures
also displayed an increasing 8N population over the course of
the experiment (Fig. 2D). The population of AurA mutant
cells with 4N or greater (4N) DNA content increased from
	50% at time zero to 	80% at 96 h, while the 4N population
in control cells remained near 50% across all of the time points
tested.
PH3 is widely used as a marker of mitotic cells. PH3 immu-
noreactivity is detectable in punctate foci at centromeres be-
ginning in G2 phase and spreads across the chromatin just
prior to chromosome condensation in prophase (31). To de-
termine if the increased 4N population in AurA mutant cul-
tures was attributable to mitotic arrest, we analyzed the PH3
index of cells with 4N and 8N DNA contents. Both wild-type
(WT) and AurA-deficient cultures displayed a peak PH3 index
at 28 h, with reduced levels at each subsequent time point (Fig.
2E). AurA-deficient cells showed an approximately threefold
higher peak PH3 index than controls at 28 h and maintained a
higher PH3 index than controls at each time point until 96 h.
PH3 cells were observed in the 4N population, as expected,
but also in the 8N population, indicating that some polyploid
cells enter mitosis (data not shown). AurA-deficient cells at
later time points displayed large, aberrant nuclei with frequent
micronuclei (Fig. 2F), indicating that AurA deficiency causes
mitotic abnormalities over the course of multiple cell cycles.
Together, these data suggest that AurA deficiency causes a
mitotic-arrest phenotype. It is notable that the peak PH3 index
in AurA mutant cultures was only 	7%, while the 4N and 8N
populations accounted for up to 80% of the total cells. This
discrepancy likely reflects the fact that AurA mutant cells are
delayed in mitotic entry (see below), such that the true peak
mitotic index was later in mutant cultures and was not captured
at the time points chosen for this experiment.
AurA-deficient MEFs display impaired mitotic entry. The
fact that AurA-deficient cells showed peak PH3 levels around
the same time as controls (Fig. 2E) suggested that AurA-
deficient cells enter mitosis with approximately normal kinet-
ics. However, AurA reduction by RNAi in HeLa cells was
reported to cause a marked delay in mitotic entry (27). AurA
depletion from Xenopus extracts also causes delayed mitotic
entry, consistent with a role for AurA in the process (38, 55).
To further investigate the mitotic entry of AurA mutant MEFs,
we measured the timing of mitotic entry by live-cell imaging
(Fig. 3A; see Fig. S2 in the supplemental material). About 40%
of the cells imaged in both WT and AurA mutant cultures
entered mitosis during the imaging interval (17 to 67 h after
serum addition). However, AurA mutant cultures displayed a
median 8-h delay relative to WT cells (median time to mitotic
entry 
 24 h for / cells versus 32 h for f/f cells). At 28 h, the
time at which we measured the PH3 index in the experiment
FIG. 3. AurA-deficient cells have a mitotic entry defect. (A). Line
graphs of time-lapse imaging data showing that AurA mutant cultures
are delayed in mitotic entry after serum starvation. Graphs indicate the
cumulative percentage of cells that entered mitosis from 17 to 61 h
after serum addition. The experiment was repeated twice, with total
numbers of 84 AurA/; R26CreER/ (/) and 63 AurAf/f; R26CreER/
(f/f) samples. (B). Bar graph showing the percentage of PH3 cells in
each mitotic phase 48 h after serum addition. Cells on coverslips were
synchronized, treated with OHT, and released as described in the
legend to Fig. 2A. Coverslips were fixed 48 h after serum addition,
stained with anti-PH3 antibody, and manually scored for mitotic phase.
Genotypes are as described in the legend to Fig. 2E. The experiment
was performed with MEFs from two different embryos per genotype,
and 200 random PH3 cells were scored for each MEF line. t tests
were used to compare percentages in each phase between genotypes:
early prophase (P 
 0.0108), late prophase (P 
 0.0295), promet-
aphase (P 
 0.0422), metaphase (P 
 0.0572), and anaphase (P 

00092). (C). Example of PH3 antibody staining in an early prophase
cell. (D). Example of PH3 antibody staining in a late prophase cell.
VOL. 29, 2009 ROLES OF Aurora-A KINASE IN VIVO AND IN VITRO 1063
shown in Fig. 2E, only 	12% of the AurA mutant cells had
entered mitosis, compared to 	30% of the WT cells. In this
light, the mitotic index of 	7% observed for AurA mutant
cultures at 28 h suggests that AurA mutant cells are signifi-
cantly delayed in mitosis, as well as prior to mitotic entry.
To better understand the delay in mitotic entry and mitotic
passage of AurA-deficient MEFs, we used IF with fixed cells to
quantitate the percentage of PH3 cells in each mitotic phase
at 26, 30, and 48 h after serum addition (Fig. 3B and data not
shown). AurA mutant cultures had two striking differences
from controls. First, we noted a marked increase in prophase
cells in mutants (67% versus 38% in WT cells, P 
 0.018).
Moreover, the majority of AurA mutant prophase cells dis-
played an early prophase phenotype with moderate PH3 stain-
ing and only partially condensed chromosomes (Fig. 3C, for
example). Only 6% of prophase cells in AurA mutant cultures
showed a late prophase phenotype with fully condensed chro-
mosomes (Fig. 3A and D). In contrast, control cultures had
approximately equal percentages of early- and late prophase
cells. Although PH3 staining is widely used as a marker of
mitosis, phosphorylation of histone H3 begins in late G2 and is
thus not a definitive mitotic marker (26). Cytological features
such as chromosome condensation that have historically been
used to define mitotic entry are also not necessarily true indi-
cators that a cell has committed to mitosis (47). However,
nuclear envelope breakdown at the prophase-prometaphase
transition clearly indicates that the cell has passed the point of
no return for mitosis (47). The accumulation of early prophase
cells in AurA-deficient cultures is thus consistent with a role
for AurA in G2 progression events that prepare cells for mi-
tosis. Nevertheless, the fact that a significant percentage of
cells enter prometaphase without AurA indicates that AurA is
not absolutely required for mitotic entry in vitro.
AurA is required for bipolar spindle formation. Despite the
striking accumulation of AurA mutant cells in early prophase,
the requirement for AurA in mitotic entry is not absolute, as
prometaphase cells were also observed in AurA mutant cul-
tures (Fig. 3A). However, in stark contrast to controls, AurA
mutant cultures were nearly devoid of cells in metaphase,
anaphase, and telophase. This observation suggested that AurA
is required for key mitotic events, in addition to its role in
facilitating mitotic entry. Examination of AurA-deficient pro-
metaphase cells revealed a characteristic monopolar spindle
pattern with closely adjacent centrosomes (-tubulin) in the
center of a circular chromosome rosette (Fig. 4B, KO). This
pattern contrasts to the well-separated centrosomes and bipo-
lar spindles observed in control cells (Fig. 4B, WT). -Tubulin
staining was also slightly weaker at the centrosome(s) of some
AurA-deficient cells, with a concomitant increase in punctate
staining throughout the cells (Fig. 4B and C). Although not
dramatic, this phenotype is consistent with the reported im-
pairment of centrosome maturation in C. elegans AurA RNAi
experiments (24). Rare cells in AurAf/f; R26CreER/Rep MEFs
treated with OHT displayed bipolar spindles, suggesting the
possibility that AurA might not be absolutely required for
bipolar spindle formation. However, AurA immunostaining
demonstrated that cells with bipolar spindles always had AurA
staining at centrosomes, indicating that these cells had not
undergone Cre-mediated recombination to delete the AurA
gene (AurA staining is shown in the WT parts of Fig. 4A and
C). In contrast, cells with monopolar spindles lacked AurA
staining (Fig. 4C, KO). Thus, in contrast to the dispensable
role of AurA in mitotic entry, our data indicate that AurA is
required for bipolar spindle formation and chromosome seg-
regation in MEFs.
AurA-deficient cells are delayed in mitosis and activate the
spindle checkpoint. Monopolar spindle formation caused by
the drug monastrol causes spindle checkpoint arrest because of
FIG. 4. AurA-deficient cells that enter mitosis form monopolar
spindles. (A) AurA-deficient cells enter mitosis and phosphorylate
histone H3. DAPI, PH3, and AurA staining in WT (AurA/;
R26CreER/Rep OHT) and AurA-deficient (AurAf/f; R26CreER/Rep
OHT) MEFs 24 h after serum addition. Note the PH3-positive mi-
totic cells lacking AurA staining in the knockout (KO) part of the
panel. Scale bar 
 10 m. (B) AurA-deficient cells form monopolar
spindles. Confocal images of WT and KO cells stained for DAPI,
-tubulin (Tub; centrosomes), and -tubulin (Tub; spindles) are
shown. The WT cell shows a normal bipolar prometaphase configura-
tion. Note the characteristic monopolar spindle in the KO cell, includ-
ing the circular chromosome array surrounding the single -tubulin
focus with an astral microtubule array. Scale bar 
 5 m. (C) Centro-
somes duplicate but fail to separate in AurA-deficient cells. Confocal
images of WT and KO cells stained for DAPI, -tubulin (centro-
somes), and AurA are shown. AurA is localized on centrosomes and
adjacent spindle structures of the WT cell. Note the two closely asso-
ciated -tubulin foci in the KO cell. Scale bar 
 5 m.
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a lack of bipolar chromosome attachment and/or lack of ten-
sion (33). To determine if monopolar spindles induced by
AurA deletion in MEFs cause a similar checkpoint arrest, we
stained cells for the checkpoint protein Mad2, whose localiza-
tion at unattached kinetochores correlates with checkpoint
arrest (reviewed in reference 44). In control cells, Mad2 stain-
ing was identified on kinetochores of chromosomes during
prometaphase, when kinetochores are not attached to the mi-
totic spindle (Fig. 5A, WT). Control cells that achieved chro-
mosome alignment and attachment during metaphase lost
Mad2 staining at kinetochores (not shown). In contrast, Mad2
staining was prominent at kinetochores of AurA mutant cells
with monopolar spindles, consistent with activation of the spin-
dle checkpoint in these cells (Fig. 5A, KO, and B).
To further define the spindle checkpoint arrest in AurA-
deficient cells, we used time-lapse microscopy to determine the
mitotic transit times of / and f/f cells after OHT treatment.
AurA mutant cells spent significantly longer in mitosis than
their WT counterparts, consistent with a spindle checkpoint
arrest phenotype (Fig. 5C, P  0.001). While 90% of the WT
cells divided and exited mitosis in 1 h or less, all of the AurA
mutant cells remained in mitosis for at least 1.5 h, with a
median time of approximately 3 h (see Table S2 and Fig. S2 in
the supplemental material). Most of the AurA mutant cells
(56%) eventually exited mitosis without dividing. However,
11% failed to exit mitosis during the imaging period, remaining
in mitosis for at least 20 h. An additional 15% of the AurA
mutant cells died during mitosis (Fig. 5C; see Table S2 in the
supplemental material). About 18% of the AurA mutant cells
divided successfully, although they remained in mitosis for
nearly 2 h prior to dividing (Fig. 5C, arrows; see Table S2 in the
supplemental material). AurA immunostaining of a parallel
culture from the same experiment indicated that approxi-
mately 20% of the f/f cells had detectable AurA staining, sug-
gesting that Cre-mediated deletion of both AurA alleles only
occurred in 80% of the cells (data not shown). This suggests
that the five cells in the f/f culture that divided successfully may
represent cells that retain AurA function. Together, these find-
ings suggest that monopolar spindles formed in the absence of
AurA trigger the spindle checkpoint, eliciting mitotic arrest
and increasing the probability of cell death. The monopolar
spindles formed in the absence of AurA are thus phenotypi-
cally similar to those caused by monastrol. These data also
indicate that AurA is not required for spindle checkpoint ac-
tivity, in contrast to AurB (10, 25, 32). Together, these MEF
studies demonstrate that mAurA plays a conserved and essen-
tial role in centrosome separation and bipolar spindle assem-
bly, similar to its orthologs in Drosophila and C. elegans.
AurA is essential for embryonic development. If AurA is
critical for transition through mitosis, as indicated by the above
MEF studies, AurA-deficient embryos should arrest very early
in development. Indeed, AurAd2/d2 animals were not obtained
among 164 live-born animals from AurAd2/ intercrosses (Fig.
6A, postnatal days 0 to 7 [P0-P7]), nor among 19 embryos
examined at E7.5 (Fig. 6A, E7.5). To determine if we could
recover AurA-deficient blastocysts and to test their develop-
mental capability, we harvested blastocysts at E3.5 and cul-
tured them for 5 to 7 days to generate blastocyst outgrowths.
Of 63 blastocysts harvested from AurAd2/ intercrosses, 49
hatched from the zona pellucida, attached to the culture dish,
and produced characteristic blastocyst outgrowths with a clus-
ter of cells derived from the inner cell mass surrounded by
trophoblast-derived cells (Fig. 6B). Forty-eight of the 49
hatched embryo outgrowths were successfully genotyped by
PCR and shown to be of either the AurAd2/ or the AurA/
genotype. In contrast, 11/63 blastocysts failed to hatch and
degenerated within the zona pellucida (Fig. 6C). In addition,
FIG. 5. Monopolar spindles in AurA-deficient cells activate the spin-
dle checkpoint. (A) Mad2 stains kinetochores of AurA-deficient cells.
Cells were stained for Mad2, -tubulin (Tub), and DAPI (shown as a
merged image). WT cell shows Mad2 foci at poles and at unattached
kinetochores. Multiple Mad2 foci are visible in the central region of the
monopolar spindle in the AurA mutant cell, consistent with kinetochore
localization (bottom). Scale bars 
 5 m. (B) Confocal maximum pro-
jection image of DAPI and Mad2 staining in an AurA mutant cell. Note
the Mad2 foci in the central region near the ends of chromosomes where
kinetochores are located. Scale bar 
 5 m. (C) AurA mutant cells
experience mitotic delays and fail to divide. Line graph of time-lapse
imaging data depicting times spent in mitosis by AurA/; R26CreER/
(/) and AurAf/f; R26CreER/ (f/f) cells. Asterisks indicate cells that died.
Red arrows indicate f/f cells that divided. All other f/f cells died or exited
mitosis without dividing, while 35/36 / cells divided (see Table S2 and
Fig. S2 in the supplemental material).
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two blastocysts that were hatched at harvest failed to produce
any outgrowth. A retrospective analysis of the blastocysts that
failed to hatch or produce outgrowths showed that most ap-
peared developmentally delayed and/or had debris in the blas-
tocele cavity at harvest, suggesting that defects were already
present in blastocyst stage embryos. Genotyping confirmed
that 8 of the 13 defective blastocysts were genotyped as
AurAd2/d2, 1 was genotyped as AurAd2/, and genotypes could
not be obtained for the other 4. Taken together, these results
indicate that AurAd2/d2 embryos are produced at approximately
Mendelian ratios but are unable to hatch and grow in vitro,
while the majority of AurAd2/ and AurA/ blastocysts show
normal in vitro growth. In other experiments, we found addi-
tional blastocysts that hatched in utero but showed character-
istic cellular defects and a lack of AurA staining by IF, sug-
gesting that they too were AurAd2/d2 embryos (Fig. 7). This
indicates that AurA is not required for hatching per se but is
essential for growth and survival in vivo, such that AurAd2/d2
embryos die shortly after the blastocyst stage.
AurA mutant embryos display mitotic arrest and monopolar
spindles. The MEF results suggested that the hatching and
outgrowth defects of AurAd2/d2 embryos were likely due to
defective mitotic entry and/or defects in mitotic progression.
However, as the cell culture environment is artificial, it was
possible that in vivo phenotypes would be distinct. We rea-
soned that if the lethality of AurA-deficient embryos is due to
defective mitotic entry, embryos should have few mitotic cells,
as determined by chromosome condensation. Alternately, if
cells enter mitosis but are unable to assemble a bipolar spindle,
the embryos should have increased numbers of cells with con-
densed chromosomes and monopolar spindles. To test these
predictions, we performed whole-mount IF staining of E3.5
blastocysts (without culture) from AurAd2/ intercrosses. For
these experiments, AurA IF staining was used to score
embryos as either AurA (AurA/ or AurAd2/) or AurA
(AurAd2/d2). Eight of the 11 embryos imaged were scored as
AurA on the basis of the presence of one or more mitotic
cells with AurA staining at spindle poles (Fig. 7A, AurA). In
contrast, three embryos lacked AurA staining, indicating that
they were AurAd2/d2 (Fig. 7A, AurA). These embryos dis-
played multiple cells with condensed chromatin in circular
arrays characteristic of monopolar spindles (arrow in Fig. 7A).
Cell counts revealed that mutant embryos contained nearly
threefold fewer total cells than did AurA embryos (Fig. 7B,
top; AurA mean 
 67, AurA mean 
 24.3), while the
mitotic index (as determined by chromosome condensation)
was eightfold higher in mutants (Fig. 7B, bottom; AurA
mean 
 3.3%, AurA mean 
 28%). Some mutant embryos
also had cells with condensed chromatin patterns indicative of
apoptosis (Fig. 7C, arrowhead in the AurA part). To confirm
the monopolar spindle phenotype, embryos were stained with
antibodies to -tubulin. While AurA embryos had mitotic
cells with normal bipolar spindles (Fig. 7C, AurA), AurA
embryos displayed characteristic astral microtubule arrays
emanating from chromosome rosettes, similar to those ob-
served in MEFs (Fig. 7C, AurA). These results clearly indi-
cate that AurA mutant blastocysts have a monopolar spindle
phenotype very similar to that observed in MEFs. The obser-
vation of large numbers of cells with condensed chromatin and
a monopolar spindle phenotype suggests that the mitotic entry
impairment observed in MEFs may not be a significant phe-
notype in vivo, at least in early embryos. The early death of
AurA mutant animals is thus apparently due to an inability to
complete mitosis during the critical wave of early cell divisions
at the blastocyst stage.
To determine if AurA is also essential and plays similar roles
in later-stage embryos, we intercrossed AurAf/; R26CreER/Rep
mice and injected pregnant dams with tamoxifen at day 10.5 of
pregnancy. Embryos were harvested 2 days later and analyzed
histologically for PH3 and apoptosis (terminal deoxynucleoti-
dyltransferase-mediated dUTP-biotin nick end labeling
[TUNEL]) in the lung and the thymus. AurA deletion in
AurAf/f; R26CreER embryos caused an approximately fourfold
increase in the percentage of PH3 cells in both the thymus
and the lung compared to that in AurA/; R26CreER embryos,
indicating that AurA deletion causes a similar mitotic arrest
phenotype in later-stage embryos, as observed in blastocysts
and MEFs (Fig. 8A to C; data not shown). The majority of the
PH3 cells in mutant embryos displayed condensed chromo-
somes and prometaphase morphology, supporting the conclu-
sion that AurA is not essential for mitotic entry in vivo (Fig.
8B). AurA mutant embryos also showed a threefold increase in
the percentage of apoptotic cells in the thymus and the lung,
indicating that AurA deficiency induces apoptosis (Fig. 8D).
FIG. 6. AurAd2/d2 embryos die at the blastocyst stage. (A) Genotype
analysis of progeny from AurAd2/ intercrosses at E3.5, E7.5, and postna-
tal stages. E3.5 embryos were cultured to generate blastocyst outgrowths
and then genotyped. #, 12 embryos displayed similar in vitro phenotypes,
but genotyping was only successful for 8; P  0.05 by 2 test for Mendelian
segregation (including 12 presumed d2/d2 embryos). *, E7.5, P  0.05. **,
postnatal days 0 to 7 (P0-P7), P  0.0001. (B) In vitro blastocyst out-
growth characteristic of the AurA/ and AurAd2/ genotypes. ICM, cell
clump derived from inner cell mass; TGC, trophoblast-derived giant cell.
(C) AurAd2/d2 blastocyst after 7 days in culture. AurA mutant blastocysts
remained unhatched within the zona pellucida (ZP). (D) Representative
PCR genotyping results for blastocysts after in vitro culture. Deduced
genotypes are shown at the top. Positions of WT and d2 products are
indicated on the right. M, DNA ladder; neg, reactions run without tem-
plate DNA; pos, positive control reactions.
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Together, these data indicate that AurA deficiency causes mi-
totic arrest and apoptosis in proliferating cells in vivo.
DISCUSSION
Here we describe the generation and characterization of a
conditional null mutation in the mouse AurA gene. We show
that deletion of AurA exon 2 produces a null allele suitable for
definitively determining the roles of AurA in vivo and in pri-
mary cells ex vivo.
Roles of AurA in mitosis. Mutation or depletion of AurA
homologs in Drosophila, C. elegans, and Xenopus cultured cells
causes accumulation of mitotic cells with monopolar spindle
phenotypes, suggesting a crucial role for AurA in centrosome
separation (21, 24, 52). More recent studies have also impli-
cated AurA in timely mitotic entry in both the C. elegans and
FIG. 7. Mitotic arrest and monopolar spindles in AurAd2/d2 blastocysts. (A) Confocal maximum z projection of E3.5 blastocysts after whole-mount IF
staining. Top: AurA/ or AurAd2/ embryo with a clear AurA signal at the centrosomes of mitotic cells. DAPI was used to stain DNA. Mitotic cells are
identifiable by condensed chromosomes. Bottom: AurAd2/d2 embryo. Note the lack of AurA staining and the presence of multiple mitotic cells with
condensed chromatin. The arrow indicates a circular chromosome array indicative of a monopolar spindle. Scale bars 
 20 m. (B) AurAd2/d2 blastocysts
have significantly reduced cell numbers (top) and an increased mitotic index (bottom) relative to those of WT littermates. Embryos stained as described
for panel A were scored as WT (AurA/ or AurAd2/) or AurAd2/d2 mutants based on the presence or absence of AurA staining. Cells were counted in
serial confocal z sections and scored as mitotic or nonmitotic on the basis of chromatin condensation. Histograms show mean values for three embryos
per class. Error bars indicate standard errors. P values were derived from two-tailed t tests. (C) Apoptosis and monopolar spindles in AurAd2/d2 embryos.
Top: AurA/ or AurAd2/ embryo with normal -tubulin (Tub) staining. The arrow indicates a metaphase cell with a bipolar spindle. Bottom: AurAd2/d2
embryo. Note the multiple apoptotic bodies (arrowhead) and cells with circular chromosome arrays and astral microtubule patterns indicative of a
monopolar spindle phenotype (arrow). Images are confocal maximum z projections of a subset of z slices for each embryo. Scale bars 
 20 m.
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Xenopus systems (23, 38, 48, 55, 57). However, the role of
mammalian AurA has previously been unclear because of con-
flicting results of cell culture studies. RNAi studies with HeLa
cells suggested that AurA is required for mitotic entry via
recruitment and activation of cdk1-cyclin B at centrosomes (27,
42). AurA was also reported to contribute indirectly to cdk1-
cyclin B activation and mitotic entry via activation of the cdc25
phosphatase (13) and Polo-like kinase 1 (57). However, other
studies with HeLa or other transformed cell types reported
that AurA-depleted or -inhibited cells accumulated in mitosis
with monopolar spindle phenotypes (12, 20, 67) and in some
cases were able to complete mitosis despite a high percentage
of abnormal spindles and chromosome segregation abnormal-
ities (28). These discrepancies could be due to differences in
the reagents, cell types, and conditions employed, as well as
distinct levels of AurA inhibition inherent in RNAi and inhib-
itor studies. Our genetic model allowed us to definitively ad-
dress this issue by inducing an AurA null mutation in geneti-
cally defined primary MEFs. By inducing the mutation in
quiescent cells and examining phenotypes in a subsequent mi-
tosis, we were able to ensure that most cells entering mitosis
lack detectable AurA protein. We found that AurA-deficient
primary MEFs experience delayed mitotic entry, as evidenced
by time-lapse imaging. This delay is associated with increased
numbers of early prophase cells, supporting an important role
for AurA in committing cells to mitosis. However, AurA is not
essential for mitotic entry, as many cells clearly enter promet-
aphase. On the other hand, AurA is essential for bipolar spin-
dle formation. AurA-deficient cells that entered prometaphase
displayed a monopolar spindle phenotype and were arrested by
the spindle checkpoint. AurA-deficient cells were not observed
in metaphase, anaphase, or telophase, and live-cell imaging
indicated that most mutant cells eventually exit mitosis without
cell division. Intriguingly, a subset of AurA-deficient cells re-
mained arrested in mitosis for extended periods of time. Ver-
tebrate cells treated for extended periods with a mitotic inhib-
itor such as nocodazole, taxol, or monastrol normally exit
mitosis after several hours because of cyclin B degradation (6).
The reason for the extended mitotic arrest of AurA-deficient
cells is unclear. A subset of AurA-deficient cells also died
during mitosis, suggesting that the mitotic arrest experienced
by these cells sometimes triggers cell death stimuli. We also
observed increased apoptosis in AurA mutant embryos, indi-
cating that this phenotype is not unique to cultured cells. To-
gether, our results establish a conserved role for mammalian
AurA in bipolar spindle formation and confirm that AurA also
plays a role in mitotic entry in vitro.
AurA is essential for development. We also found that AurA
is required for mouse embryonic development. AurA-null em-
bryos survive to the blastocyst stage but are not recovered at
E7.5 or later, indicating that AurA deficiency causes lethality
at some time between E3.5 and E7.5. AurA-null blastocysts
harvested at E3.5 fail to hatch and grow in vitro and display
multiple cells arrested in mitosis with monopolar spindles.
Similar results were very recently reported by others using an
independently generated mouse AurA mutant (54). The ob-
servation of mitotic arrest and monopolar spindle formation
suggests that mitotic entry defects are not the predominant
phenotype of AurA deficiency in vivo, although we cannot rule
out a minor role. AurA is present in mouse oocytes and early
embryos, where it localizes at spindle poles (69). The survival
of AurA-deficient cells to the blastocyst stage suggests that
maternal AurA mRNA and/or protein stores are sufficient to
sustain AurA levels through the several cell divisions of early
embryogenesis. However, AurA becomes limiting at the blas-
tocyst stage, leading to defects in mutant embryos.
AurA mutation causes mitotic arrest and apoptosis in mid-
gestation. AurA deletion in mid-gestation embryos caused a
marked increase in mitotic (PH3) cells in two of the tissue
types examined (lung and thymus). As was observed in blasto-
cysts, the bulk of PH3 cells in mutant embryos displayed
condensed chromatin patterns, indicating that the cells had
entered mitosis. Together with the blastocyst data, this obser-
vation establishes that AurA is not essential for mitotic entry in
vivo. However, we cannot rule out the presence of a mitotic
delay, as was observed in MEFs.
FIG. 8. AurA deletion in mid-gestation embryos causes an increased mitotic index and apoptosis. (A). Representative PH3 staining in lung
sections from E14.5 embryos after tamoxifen treatment at E12.5. (B). Quantitation of PH3 cells in lung tissue from E14.5 embryos after tamoxifen
treatment at E12.5. (C). Left: representative TUNEL of a lung section from an E14.6 AurAf/f; R26CreER/Rep embryo after tamoxifen treatment at
E12.5. Right: magnified image from the box in the left part of the panel showing examples of TUNEL cells (brown). (D). Quantitation of
TUNEL cells in lung tissue from an E14.5 embryo after tamoxifen treatment at E12.5.
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The increased mitotic index in AurA mutant mid-gestation
embryos was accompanied by a parallel increase in apoptotic
cells. Apoptotic chromatin patterns were also observed in
AurA-deficient blastocysts, indicating that this phenotype is
not restricted to later gestation embryos. As discussed above, a
subset of AurA-deficient MEFs died during mitosis. An im-
portant area for future work will be the determination of the
signaling pathways that govern apoptosis in response to AurA
mutation.
AurA as a therapeutic target in cancer. The important roles
of Aurora kinases in mitotic regulation, as well as the finding
that AurA is overexpressed in many human cancers, have
raised considerable interest in AurA kinase inhibitors as po-
tential cancer therapeutics. Indeed, Aurora kinase inhibitors
are currently in clinical trials (reviewed in references 9 and 34).
Several currently described Aurora inhibitors display activity
against both AurA and AurB in vitro (20, 67), while com-
pounds with reported selectivity for AurA or AurB inhibition
are beginning to emerge (20, 28, 68). The desirability of tar-
geting AurA, AurB, or both is a matter of debate (9, 65, 67).
Nevertheless, our results clarify the issue by clearly defining the
AurA mutant phenotype. Thus, we predict that potent AurA-
specific inhibitors should cause monopolar spindles, leading to
mitotic arrest in cells with a competent spindle checkpoint. In
contrast, inhibition of AurB alone and dual inhibition of AurA
and AurB have been reported to produce similar phenotypes,
including rapid mitotic exit without cell division because of loss
of the spindle checkpoint and cytokinesis impairment (20, 67).
Activation of the spindle checkpoint in specific AurA-inhibited
cells is thus a significant functional difference that may con-
tribute to distinct therapeutic outcomes. The long-term conse-
quences of spindle checkpoint arrest are not fully defined but
may include apoptosis, mitotic catastrophe, mitotic exit, and
subsequent G1 arrest or mitotic exit followed by endoredupli-
cation (reviewed in reference 51). Our results suggest that at
least a subset of cells treated with AurA inhibitors should
undergo apoptosis, although it is possible that tumor cells may
respond differently from normal primary cells. Our genetic
system will allow future tests of these hypotheses in vivo and in
vitro.
The challenge of obtaining AurA-specific inhibitors raises
the question of whether similar therapeutic effects could be
achieved by targeting other molecules. Our results suggest that
drugs such as monastrol that cause monopolar spindles by
inhibiting the mitotic kinesin Eg5 may be good alternatives to
AurA inhibitors. Several such drugs are under development
(4). While these compounds may not show phenotypes identi-
cal to that produced by AurA inhibition (because of the fact
that AurA has substrates involved in multiple aspects of mito-
sis and also regulates processes outside of mitosis [49]), they
may cause a phenotypically similar arrest state with similar
biological outcomes. In fact, Eg5 is a substrate of AurA in
Xenopus, suggesting that Eg5 activation could be downstream
of AurA. The future identification of the AurA targets medi-
ating the monopolar spindle phenotype will also be helpful in
exploring other ways to target this pathway for therapeutic
benefit.
In summary, these studies provide clear evidence that mam-
malian AurA is essential for viability because of its key role in
regulating the transition through M phase, specifically in the
establishment of bipolar spindle assembly. The conditional ge-
netic system established in this report, with paired primary cell
and in vivo studies, will be instrumental in deciphering the
mechanisms and pathways involved. Furthermore, the role(s)
of AurA in cancer and other diseases associated with aneu-
ploidy can now be fully explored.
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